AMARIN CORP PLC\UK Increase (Decrease) in Restricted Cash
AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Restricted Cash of -$400.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2016-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2016-02-25
- AMARIN CORP PLC\UK increase (decrease) in restricted cash for the quarter ending 2014-12-31 was $0.00.
- AMARIN CORP PLC\UK increase (decrease) in restricted cash for the quarter ending 2014-09-30 was $0.00.
- AMARIN CORP PLC\UK increase (decrease) in restricted cash for the quarter ending 2014-06-30 was $0.00.
- AMARIN CORP PLC\UK increase (decrease) in restricted cash for the quarter ending 2014-03-31 was -$400.00K, a 128.57% decline year-over-year.
- AMARIN CORP PLC\UK increase (decrease) in restricted cash for fiscal 2014 was -$400.00K, a 140.00% decline from fiscal 2013.
- AMARIN CORP PLC\UK increase (decrease) in restricted cash for fiscal 2013 was $1.00M.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $0.00 derived: sum of 2 quarters · filed 2016-02-25 | $0.00 derived: sum of 3 quarters · filed 2016-02-25 | -$400.00K 10-K · filed 2016-02-25 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $0.00 derived: sum of 2 quarters · filed 2015-11-04 | -$400.00K 10-Q · filed 2015-11-04 | -$800.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$400.00K 10-Q · filed 2015-08-06 | -$800.00K derived: sum of 3 quarters · filed 2016-02-25 | -$800.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$400.00K 10-Q · filed 2015-05-08 | -$800.00K derived: sum of 2 quarters · filed 2016-02-25 | -$800.00K derived: sum of 3 quarters · filed 2016-02-25 | -$800.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | -$400.00K derived: sum of 2 quarters · filed 2016-02-25 | -$400.00K derived: sum of 3 quarters · filed 2016-02-25 | $1.00M 10-K · filed 2016-02-25 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | $1.40M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.40M 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $1.40M 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |